Cite
Virus modified tumor cell vaccines for active specific immunotherapy of micrometastases: expansion and activation of tumor-specific T cells.
MLA
Schirrmacher, V., et al. “Virus Modified Tumor Cell Vaccines for Active Specific Immunotherapy of Micrometastases: Expansion and Activation of Tumor-Specific T Cells.” Progress in Clinical and Biological Research, vol. 288, 1989, pp. 391–99. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2785693&authtype=sso&custid=ns315887.
APA
Schirrmacher, V., von Hoegen, P., & Heicappell, R. (1989). Virus modified tumor cell vaccines for active specific immunotherapy of micrometastases: expansion and activation of tumor-specific T cells. Progress in Clinical and Biological Research, 288, 391–399.
Chicago
Schirrmacher, V, P von Hoegen, and R Heicappell. 1989. “Virus Modified Tumor Cell Vaccines for Active Specific Immunotherapy of Micrometastases: Expansion and Activation of Tumor-Specific T Cells.” Progress in Clinical and Biological Research 288: 391–99. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2785693&authtype=sso&custid=ns315887.